Get the Stockscreener App
12.76
1.27%
0.16
After Hours:
10.62
-2.14
-16.77%
Nextcure Inc stock is traded at $12.76, with a volume of 76,132.
It is up +1.27% in the last 24 hours and up +15.06% over the past month.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
See More
Previous Close:
$12.60
Open:
$12.22
24h Volume:
76,132
Relative Volume:
2.14
Market Cap:
$44.73M
Revenue:
-
Net Income/Loss:
$-58.52M
P/E Ratio:
-6.1053
EPS:
-2.09
Net Cash Flow:
$-45.03M
1W Performance:
-1.85%
1M Performance:
+15.06%
6M Performance:
+163.09%
1Y Performance:
+1,624%
1-Day Range:
$11.63
$12.99
1-Week Range:
$10.58
$13.26
52-Week Range:
$0.224
$15.74
Nextcure Inc Stock (NXTC) Company Profile
Name
Nextcure Inc
Sector
Industry
Phone
240-399-4900
Address
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Compare NXTC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
12.76 | 44.17M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Nov-04-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| Mar-05-21 | Upgrade | Truist | Hold → Buy |
| Jan-15-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-16-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-13-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-13-20 | Downgrade | SunTrust | Buy → Hold |
| Jun-01-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-01-20 | Downgrade | The Benchmark Company | Buy → Hold |
| May-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Mar-24-20 | Initiated | The Benchmark Company | Buy |
| Mar-02-20 | Initiated | ROTH Capital | Buy |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Dec-05-19 | Initiated | Needham | Buy |
| Nov-26-19 | Initiated | BTIG Research | Buy |
| Jul-09-19 | Initiated | BofA/Merrill | Buy |
| Jun-03-19 | Initiated | Morgan Stanley | Overweight |
| Jun-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Nextcure Inc Stock (NXTC) Latest News
NextCure Provides Business Update and Reports Full Year 2025 Financial Results - The Manila Times
NXTC SEC FilingsNextcure 10-K, 10-Q, 8-K Forms - Stock Titan
NextCure Inc expected to post a loss of $2.42 a shareEarnings Preview - TradingView
Hedge Fund Bets: Is NextCure Inc stock good for income investorsJuly 2025 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
NextCure (NXTC) Projected to Post Quarterly Earnings on Thursday - Defense World
Published on: 2026-02-26 09:55:29 - baoquankhu1.vn
NextCure (NASDAQ:NXTC) Stock Price Down 3.7% – What’s Next? - Defense World
Can NextCure Inc. stock double in next 5 yearsWeekly Investment Report & Technical Entry and Exit Tips - mfd.ru
Squadron funds disclose 9.99% holding in NextCure (NXTC) common stock - Stock Titan
Will The Allstate Corporation stock benefit from green energy trendsIPO Watch & Weekly Return Optimization Alerts - mfd.ru
NXTC Technical Analysis & Stock Price Forecast - Intellectia AI
Is FSLR stock a top pick in earnings seasonMarket Trend Summary & Precise Swing Trade Alerts - mfd.ru
Street Watch: Is NextCure Inc stock showing strong momentumGap Down & Community Verified Trade Signals - baoquankhu1.vn
Cancer index surges 72% as Terns, Olema lead gains - BioWorld MedTech
Aug Catalysts: Is NextCure Inc stock showing strong momentumJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Fund Flows: What is LanzaTech Global Inc. Equity Warrant s revenue forecastMarket Movement Recap & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
NextCure provides updates on ADC programs, reports cash position By Investing.com - Investing.com South Africa
NextCure Provides Business Update - citybiz
NextCure Updates ADC Pipeline Progress and Cash Runway - TipRanks
Next Cure Highlights Progress Across ADC Pipeline As Company Extends Cash Runway Into 2027 - Nasdaq
NextCure provides updates on ADC programs, reports cash position - Investing.com
NextCure provides business update - marketscreener.com
NextCure Provides Business Update - GlobeNewswire Inc.
NXTC: SIM0505 and LNCB74 advance in Phase 1, with strong efficacy and key data expected in 2026 - TradingView
Is Concord Medical Services Holdings Limited stock included in top ETFsJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - bollywoodhelpline.com
Market Outlook: What’s the RSI of ON24 Inc. stockJuly 2025 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Buyout Rumor: Can NextCure Inc stock deliver 10 annual returnsWeekly Risk Summary & Safe Entry Point Identification - Bộ Nội Vụ
Aug Setups: How liquid is NextCure Inc stockPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
What margin trends mean for NextCure Inc. stock2025 Institutional Moves & Stock Timing and Entry Methods - Улправда
Will NextCure Inc. stock remain a Wall Street favorite2025 Technical Patterns & Weekly Breakout Stock Alerts - ulpravda.ru
Will Banzai International Inc. Equity Warrant stock deliver better than expected guidance - Улправда
Will NextCure Inc. stock maintain growth storyMarket Activity Report & Scalable Portfolio Growth Methods - Улправда
Will NextCure Inc. stock benefit from automation2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
How analysts revise price targets for XYZY stockEarnings Beat & Free Real-Time Volume Trigger Notifications - Улправда
Will CO2 Energy Transition Corp. Equity Right stock outperform international peers2025 Price Targets & Low Drawdown Trading Strategies - ulpravda.ru
Why Intellinetics Inc. stock is trending among retail tradersLayoff News & Technical Buy Zone Confirmation - Улправда
How institutional buying supports NextCure Inc. stock2025 EndofYear Setup & Daily Profit Focused Screening - Улправда
Is NextCure Inc. stock resilient to inflationBull Run & High Yield Equity Trading Tips - Улправда
Risk Off: Why retail investors favor DRVN stock2025 AllTime Highs & Short-Term Trading Opportunity Alerts - moha.gov.vn
NextCure stock plunges to 52-week low, hits $0.69 - MSN
The Truth About NextCure Inc (NXTC): Hidden Biotech Underdog or Total Flop Stock? - AD HOC NEWS
Machinery Limited Builds Base for Possible ReboundFundamental Strength Indicators & Explosive Profit Growth - bollywoodhelpline.com
Options Data Show Bullish Bias in Foseco India LimitedValue Traps to Avoid & Explosive Profit Trading - bollywoodhelpline.com
Biocon Limited (BIOCON) vs yyyLong-Term Growth Stocks & Minimal Capital Growth Ideas - bollywoodhelpline.com
Jewellery Limited (LYPSAGEMS) Hits 52 Week HighDividend Stability Analysis & High Profit Investment Ideas - bollywoodhelpline.com
Short Interest in NextCure, Inc. (NASDAQ:NXTC) Expands By 29.6% - Defense World
Growth Review: Will NextCure Inc stock remain a Wall Street favoritePortfolio Value Summary & Fast Momentum Entry Tips - moha.gov.vn
Geopolitics Watch: Is NextCure Inc stock resilient to inflationEarnings Summary Report & Scalable Portfolio Growth Ideas - moha.gov.vn
Everest Kanto Cylinder Limited Stock Lags Behind Sector BenchmarksMarket Sentiment Indicators & Superior Trading Portfolio - Bollywood Helpline
Analyzing Monte Rosa Therapeutics (NASDAQ:GLUE) and NextCure (NASDAQ:NXTC) - Defense World
Nextcure Inc Stock (NXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):